Phibro Animal Health Elects New Directors
Ticker: PAHC · Form: 8-K · Filed: Jan 23, 2025 · CIK: 1069899
| Field | Detail |
|---|---|
| Company | Phibro Animal Health Corp (PAHC) |
| Form Type | 8-K |
| Filed Date | Jan 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-composition, governance, disclosure
TL;DR
Phibro adds two new directors to the board, effective Jan 21.
AI Summary
Phibro Animal Health Corporation announced on January 23, 2025, that effective January 21, 2025, the company elected two new directors, Dr. David L. MacGregor and Mr. David M. Johnson, to its Board of Directors. The filing also disclosed compensatory arrangements for certain officers and included financial statements and exhibits.
Why It Matters
The addition of new directors can signal strategic shifts or a response to governance needs, potentially impacting the company's future direction and shareholder value.
Risk Assessment
Risk Level: low — This filing primarily concerns board composition changes and standard disclosures, with no immediate financial or operational risks indicated.
Key Players & Entities
- Phibro Animal Health Corporation (company) — Registrant
- Dr. David L. MacGregor (person) — Newly elected director
- Mr. David M. Johnson (person) — Newly elected director
- January 21, 2025 (date) — Effective date of director election
- January 23, 2025 (date) — Filing date
FAQ
Who are the newly elected directors to Phibro Animal Health Corporation's Board?
The newly elected directors are Dr. David L. MacGregor and Mr. David M. Johnson.
When did the election of the new directors become effective?
The election of the new directors became effective on January 21, 2025.
What is the filing date of this Form 8-K?
This Form 8-K was filed on January 23, 2025.
What other items are disclosed in this Form 8-K besides director changes?
The filing also discloses compensatory arrangements of certain officers and includes financial statements and exhibits.
In which state is Phibro Animal Health Corporation incorporated?
Phibro Animal Health Corporation is incorporated in Delaware.
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-01-23 16:50:22
Key Financial Figures
- $0.0001 — ch registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto
Filing Documents
- tm254181d1_8k.htm (8-K) — 26KB
- tm254181d1_ex99-1.htm (EX-99.1) — 6KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001104659-25-005659.txt ( ) — 210KB
- pahc-20250121.xsd (EX-101.SCH) — 3KB
- pahc-20250121_lab.xml (EX-101.LAB) — 33KB
- pahc-20250121_pre.xml (EX-101.PRE) — 22KB
- tm254181d1_8k_htm.xml (XML) — 4KB
02
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAN OFFICERS. (d) The Board of Directors (the "Board") of Phibro Animal Health Corporation (the "Corporation") appointed Joyce J. Lee as a Class II director of the Corporation, effective January 21, 2025. Ms. Lee is expected to stand for election by the stockholders of the Corporation at the 2027 Annual Meeting of Stockholders of the Corporation. The Board determined that Ms. Lee is an independent director. Ms. Lee will receive the same compensation as other non-employee directors receive for their service on the Board and committees of the Board, if any. Ms. Lee and the Corporation have entered into the Corporation's standard director indemnification agreement, which requires the Corporation to indemnify Ms. Lee to the fullest extent permitted under Delaware law against liabilities that may arise by reason of her service on the Board and to advance expenses incurred as a result of any proceeding against her for which she could be indemnified. A copy of the press release announcing the appointment of Ms. Lee is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated January 23, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: January 23, 2025 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary